(2R)-2-[(3S,7R,8S,9S,10R,13S,14S,16S,17R)-7-hydroxy-10,13-dimethyl-3,16-bis[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylheptan-4-one

Details

Top
Internal ID 5eec31d7-b0f0-4913-8107-c00be814c1f9
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides
IUPAC Name (2R)-2-[(3S,7R,8S,9S,10R,13S,14S,16S,17R)-7-hydroxy-10,13-dimethyl-3,16-bis[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylheptan-4-one
SMILES (Canonical) CC(C)CC(=O)CC(C)C1C(CC2C1(CCC3C2C(C=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)OC6C(C(C(C(O6)CO)O)O)O
SMILES (Isomeric) C[C@H](CC(=O)CC(C)C)[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C=C4[C@@]3(CC[C@@H](C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)O)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O
InChI InChI=1S/C39H64O14/c1-17(2)10-20(42)11-18(3)29-25(51-37-35(49)33(47)31(45)27(16-41)53-37)14-23-28-22(7-9-39(23,29)5)38(4)8-6-21(12-19(38)13-24(28)43)50-36-34(48)32(46)30(44)26(15-40)52-36/h13,17-18,21-37,40-41,43-49H,6-12,14-16H2,1-5H3/t18-,21+,22+,23+,24+,25+,26-,27-,28-,29+,30-,31-,32+,33+,34-,35-,36-,37-,38+,39+/m1/s1
InChI Key AJUXWMBUYRRTJS-YFAMFGMBSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C39H64O14
Molecular Weight 756.90 g/mol
Exact Mass 756.42960671 g/mol
Topological Polar Surface Area (TPSA) 236.00 Ų
XlogP 0.90
Atomic LogP (AlogP) 0.16
H-Bond Acceptor 14
H-Bond Donor 9
Rotatable Bonds 11

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2R)-2-[(3S,7R,8S,9S,10R,13S,14S,16S,17R)-7-hydroxy-10,13-dimethyl-3,16-bis[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylheptan-4-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7907 79.07%
Caco-2 - 0.8811 88.11%
Blood Brain Barrier - 0.6250 62.50%
Human oral bioavailability - 0.8143 81.43%
Subcellular localzation Mitochondria 0.8651 86.51%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8458 84.58%
OATP1B3 inhibitior - 0.4111 41.11%
MATE1 inhibitior - 0.9812 98.12%
OCT2 inhibitior - 0.6276 62.76%
BSEP inhibitior - 0.6252 62.52%
P-glycoprotein inhibitior + 0.7053 70.53%
P-glycoprotein substrate - 0.5760 57.60%
CYP3A4 substrate + 0.7303 73.03%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8581 85.81%
CYP3A4 inhibition - 0.9642 96.42%
CYP2C9 inhibition - 0.8723 87.23%
CYP2C19 inhibition - 0.9158 91.58%
CYP2D6 inhibition - 0.9399 93.99%
CYP1A2 inhibition - 0.8907 89.07%
CYP2C8 inhibition + 0.5237 52.37%
CYP inhibitory promiscuity - 0.9193 91.93%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.6168 61.68%
Eye corrosion - 0.9898 98.98%
Eye irritation - 0.9216 92.16%
Skin irritation - 0.5922 59.22%
Skin corrosion - 0.9456 94.56%
Ames mutagenesis - 0.6977 69.77%
Human Ether-a-go-go-Related Gene inhibition + 0.7967 79.67%
Micronuclear - 0.8700 87.00%
Hepatotoxicity - 0.7757 77.57%
skin sensitisation - 0.9044 90.44%
Respiratory toxicity + 0.6667 66.67%
Reproductive toxicity + 0.9000 90.00%
Mitochondrial toxicity - 0.6250 62.50%
Nephrotoxicity - 0.6815 68.15%
Acute Oral Toxicity (c) III 0.7126 71.26%
Estrogen receptor binding + 0.7921 79.21%
Androgen receptor binding + 0.7037 70.37%
Thyroid receptor binding - 0.5838 58.38%
Glucocorticoid receptor binding - 0.4751 47.51%
Aromatase binding + 0.6337 63.37%
PPAR gamma + 0.6715 67.15%
Honey bee toxicity - 0.7012 70.12%
Biodegradation - 0.7000 70.00%
Crustacea aquatic toxicity - 0.6855 68.55%
Fish aquatic toxicity + 0.9649 96.49%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.62% 96.09%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 97.20% 94.45%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.92% 91.11%
CHEMBL2581 P07339 Cathepsin D 94.04% 98.95%
CHEMBL3137262 O60341 LSD1/CoREST complex 92.94% 97.09%
CHEMBL226 P30542 Adenosine A1 receptor 92.78% 95.93%
CHEMBL237 P41145 Kappa opioid receptor 92.72% 98.10%
CHEMBL1994 P08235 Mineralocorticoid receptor 89.87% 100.00%
CHEMBL5608 Q16288 NT-3 growth factor receptor 89.73% 95.89%
CHEMBL253 P34972 Cannabinoid CB2 receptor 87.43% 97.25%
CHEMBL1806 P11388 DNA topoisomerase II alpha 83.94% 89.00%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 82.54% 95.56%
CHEMBL5103 Q969S8 Histone deacetylase 10 81.33% 90.08%
CHEMBL2007 P16234 Platelet-derived growth factor receptor alpha 81.25% 91.07%
CHEMBL5255 O00206 Toll-like receptor 4 80.60% 92.50%
CHEMBL5028 O14672 ADAM10 80.41% 97.50%
CHEMBL221 P23219 Cyclooxygenase-1 80.38% 90.17%
CHEMBL220 P22303 Acetylcholinesterase 80.36% 94.45%

Cross-Links

Top
PubChem 101620741
NPASS NPC126142
LOTUS LTS0039819
wikiData Q104913407